Literature DB >> 18721325

Allergy and the nose.

G Ciprandi1, G Passalacqua.   

Abstract

Allergic rhinitis (AR) is the most common immunological disorder and is characterized by an immunoglobulin E (IgE)-mediated inflammation induced by the allergen exposure. This review will consider some issues concerning pathophysiological aspects of AR: impact on asthma, response to decongestion, link with infections, response to specific immunotherapy, relationship with adiposity, effects on quality of life (QoL) and allergic inflammation. AR, even though not a serious illness, may be a clinically relevant disorder as it may present numerous complications and affect QoL, as reported in this review. Therefore, the management of AR patients should be rigorously careful and multi-disciplinary.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721325      PMCID: PMC2515355          DOI: 10.1111/j.1365-2249.2008.03717.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Association between asthma and rhinitis according to atopic sensitization in a population-based study.

Authors:  Bénédicte Leynaert; Catherine Neukirch; Sabine Kony; Armelle Guénégou; Jean Bousquet; Michel Aubier; Françoise Neukirch
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

Review 2.  Nasal involvement in allergic asthma.

Authors:  G-J Braunstahl; W Fokkens
Journal:  Allergy       Date:  2003-12       Impact factor: 13.146

3.  Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism.

Authors:  C Tang; M D Inman; N van Rooijen; P Yang; H Shen; K Matsumoto; P M O'Byrne
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects.

Authors:  R G Townley; U Y Ryo; B M Kolotkin; B Kang
Journal:  J Allergy Clin Immunol       Date:  1975-12       Impact factor: 10.793

5.  Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma.

Authors:  S S Braman; A A Barrows; B A DeCotiis; G A Settipane; W M Corrao
Journal:  Chest       Date:  1987-05       Impact factor: 9.410

6.  Immunomodulation during sublingual therapy in allergic children.

Authors:  Flora Ippoliti; Wladimiro De Santis; Anna Volterrani; Luisa Lenti; Nicoletta Canitano; Sandra Lucarelli; Tullio Frediani
Journal:  Pediatr Allergy Immunol       Date:  2003-06       Impact factor: 6.377

7.  Nasal obstruction in patients with seasonal allergic rhinitis: relationships between allergic inflammation and nasal airflow.

Authors:  Giorgio Ciprandi; Ignazio Cirillo; Andrea Vizzaccaro; Manlio Milanese; Maria Angela Tosca
Journal:  Int Arch Allergy Immunol       Date:  2004-03-25       Impact factor: 2.749

8.  Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways.

Authors:  G-J Braunstahl; W J Fokkens; S E Overbeek; A KleinJan; H C Hoogsteden; J-B Prins
Journal:  Clin Exp Allergy       Date:  2003-05       Impact factor: 5.018

9.  Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation.

Authors:  S Hutchison; B S W Choo-Kang; R V Bundick; A J Leishman; J M Brewer; I B McInnes; P Garside
Journal:  Clin Exp Immunol       Date:  2007-10-11       Impact factor: 4.330

10.  Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis.

Authors:  S R Downie; M Andersson; J Rimmer; J D Leuppi; W Xuan; A Akerlund; J K Peat; C M Salome
Journal:  Allergy       Date:  2004-03       Impact factor: 13.146

View more
  1 in total

1.  Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens.

Authors:  Aino Rantala; Jouni J K Jaakkola; Maritta S Jaakkola
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.